Grant Bochicchio, MD
Surgical Critical Care · Saint Louis, MONPI 1255388906
Payments from drug & device makers
Across 268 payments — averaging $11,570 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$2.5M
- Abbott$314K
- Musculoskeletal Transplant Foundation Inc.$89K
- Solventum Corporation$62K
- Sealonix Inc.$29K
- KCI USA, Inc.$26K
- plus $48K from 11 others
Across 1 payment — averaging $9520.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Integra Lifesciences Corporation$10K
What the payments were for
- Consulting fees$16,59244%
- Speaking & faculty fees$3,2509%
- Travel & lodging$7,11319%
- Food & beverage$2,9858%
- Education$8,00021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 86 | $2,534,170 |
| Abbott | 99 | $313,948 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $88,604 |
| Solventum Corporation | 8 | $61,686 |
| Sealonix Inc. | 3 | $28,648 |
| KCI USA, Inc. | 2 | $25,742 |
| Integra Lifesciences Corporation | 6 | $20,563 |
| Intuitive Surgical | 30 | $10,915 |
| Johnson & Johnson(2 entities) | 8 | $7,187 |
| Dexcom, Inc. | 1 | $3,250 |
| Surgalign Spine Technologies, Inc. | 1 | $2,500 |
| TELA Bio, Inc. | 13 | $1,832 |
| W. L. Gore & Associates, Inc. | 4 | $1,311 |
| Reprise Biomedical, Inc. | 1 | $176 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $167 |
| AstraZeneca | 1 | $24 |
| Kerecis Limited | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,546
- NEURAGEN$5,625
- TENOGLIDE$5,625
- DAVINCI XI$4,000
- SURGICEL NU-KNIT$3,900
- DEXCOM G6 TRANSMITTER$3,250
- EVARREST$3,017
- VISTASEAL$3,017
- TUTOPATCH BOVINE PERICARDIUM$2,500
- Ovitex$1,313
- Product in Development$900
- ABTHERA$650
- FLOWABLE$314
- BILAYER WOUND MATRIX (BWM)$314
- GORE ENFORM Preperitoneal Biomaterial$268
- MIRO3D$176
- SYNECOR Biomaterial$144
- ECHELON ENDOPATH Stapler$109
- CODMAN HAKIM PRECISION VALVE$104
- CODMAN CERTAS$104
How this compares
$3,100,737 in reported general payments places this provider in the 95th percentile of 35 surgical critical care providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CholestyramineCholestyramine (With Sugar) | 11 | $1,223 |
| Neomycin Sulfate | 28 | $148 |
| Metronidazole | 27 | $65 |
| Ondansetron Hcl | 21 | $59 |
| Pantoprazole Sodium | 13 | $26 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in Saint Louis
- Charlie SrivilasaSaint Louis$11K
- Zachary EnglertSaint Louis$9K
- Michael KeirseySaint Louis$3K
- Lindsay KrankerSaint Louis$3K
- Mark HoofnagleSaint Louis$2K
- Chen WangSaint Louis$1K
- Victoria CuiSaint Louis$1K
- Lauren SchmidtSaint Louis$1K
- Rahul SharmaSaint Louis$886
- Douglas SchuererSaint Louis$885
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.